Roche plans no major acquisitions, spin-offs possible - head of pharma |
|
|
|
Published
:
Wed, 18 Apr 2007 07:00
|
ZURICH (Thomson Financial) - Roche Holdings AG's does not plan any significant acquisitions, but aims to achieve growth through the development of its own products as well as through cooperation and licenses, the group's head of pharma William Burns said.'Roche is definitely not relying on mega-mergers,' Burns said in an interview with Swiss weekly Handelszeitung.Burns said he did not think mergers were 'the ideal way,' to achieve growth and that instead Roche will seek to grow on the back of its own products, licenses and cooperation.He added that the group does not exclude the option of further spin-offs either.Earlier today, Roche reported first quarter group sales at the high-end of expectations of 11.4 bln sfr, up 16 pct year-on-year in Swiss franc terms, and confirmed its full-year guidance for double-digit sales growth at both group level and in the pharma division.Roche also upgraded its target for EPS growth to 'above group sales', from its previous growth target of 'in-line with sales growth'.johanna.treeck@thomson.comjmt/lamCOPYRIGHTCopyright AFX News Limited 2007. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
1384.35 |
+68.23 (
5.07 %)
|
| SYMBOL (
2008-11-21 ) |
| LAST |
CHANGE
|
|
RIO TINTO
(
11:29am )
|
|
2100.00 |
+78.00 (
3.72 %)
|
| SYMBOL (
2008-11-21 )
|
| LAST |
CHANGE
|
|
IBM
(
4:01pm ) |
|
74.88 |
+3.14 (
4.32 %)
|
| SYMBOL (
2008-11-21 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Roche acquires US-German co Therapeutic Human Polyclonals for 56.6 mln usd 